Harr Clinical Chemistry Practice Test

The cutoff value of 6.5% for glycated hemoglobin (HbA1c) is significant as it is aligned with the American Diabetes Association's (ADA) recommendations for assessing long-term glycemic control in individuals with diabetes. The HbA1c test reflects average blood glucose levels over the past two to three months, providing a more comprehensive view of glucose management compared to daily blood glucose measurements.

An HbA1c level of 6.5% indicates that an individual's average blood glucose level over that period is approximately 140 mg/dL. This threshold is important because maintaining an HbA1c level below this value is associated with a reduced risk of diabetes-related complications, such as neuropathy, nephropathy, and retinopathy. Thus, the recommendation of 6.5% serves as a critical benchmark for healthcare providers when formulating treatment plans and assessing the effectiveness of diabetes management strategies.

Values below 6.5% generally indicate better glycemic control, while higher values suggest the necessity for adjustments in therapy to enhance glucose regulation.